Found: 30
Select item for more details and to access through your institution.
41.8°C whole body hyperthermia as an adjunct to chemotherapy induces prolonged T cell activation in patients with various malignant diseases.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 11-12, p. 603, doi. 10.1007/s00262-002-0327-x
- By:
- Publication type:
- Article
Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2011, v. 86, n. 11, p. 918, doi. 10.1002/ajh.22141
- By:
- Publication type:
- Article
Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice.
- Published in:
- International Journal of Cancer, 2002, v. 98, n. 5, p. 785, doi. 10.1002/ijc.10206
- By:
- Publication type:
- Article
Impact of the Localization of the Primary Tumor and RAS/BRAF Mutational Status on Maintenance Strategies After First-line Oxaliplatin, Fluoropyrimidine, and Bevacizumab in Metastatic Colorectal Cancer: Results From the AIO 0207 Trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
BRAF testing in metastatic colorectal carcinoma and novel, chemotherapy-free therapeutic options.
- Published in:
- Der Pathologe, 2021, v. 42, p. 98, doi. 10.1007/s00292-021-00946-5
- By:
- Publication type:
- Article
BRAF-V600E-Testung beim metastasierten kolorektalen Karzinom und neue, chemotherapiefreie Therapieoptionen.
- Published in:
- Der Pathologe, 2021, v. 42, n. 6, p. 578, doi. 10.1007/s00292-021-00942-9
- By:
- Publication type:
- Article
Prolonged inhibition of von Willebrand factor-cleaving protease after splenectomy in a 22-year-old patient with acute and plasma refractory thrombotic thrombocytopenic purpura.
- Published in:
- British Journal of Haematology, 2002, v. 118, n. 1, p. 271, doi. 10.1046/j.1365-2141.2002.03566.x
- By:
- Publication type:
- Article
Microsatellite instability (MSI-H) is associated with a high immunoscore but not with PD-L1 expression or increased survival in patients (pts.) with metastatic colorectal cancer (mCRC) treated with oxaliplatin (ox) and fluoropyrimidine (FP) with and without bevacizumab (bev): a pooled analysis of the AIO KRK 0207 and RO91 trials
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 10, p. 3063, doi. 10.1007/s00432-021-03559-w
- By:
- Publication type:
- Article
Clinical Practice Observation of Trastuzumab in Patients with Human Epidermal Growth Receptor 2‐Positive Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction.
- Published in:
- Oncologist, 2020, v. 25, n. 8, p. e1181, doi. 10.1634/theoncologist.2020-0109
- By:
- Publication type:
- Article
Intraperitoneal VEGF Inhibition Using Bevacizumab: A Potential Approach for the Symptomatic Treatment of Malignant Ascites?
- Published in:
- Oncologist, 2009, v. 14, n. 12, p. 1242, doi. 10.1634/theoncologist.2009-0109
- By:
- Publication type:
- Article
Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: A subgroup analysis from AIO-PK0104.
- Published in:
- Acta Oncologica, 2015, v. 54, n. 7, p. 993, doi. 10.3109/0284186X.2015.1034877
- By:
- Publication type:
- Article
T cell responses against tumor associated antigens and prognosis in colorectal cancer patients.
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 3, doi. 10.1186/1479-5876-3-3
- By:
- Publication type:
- Article
Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavity.
- Published in:
- European Archives of Oto-Rhino-Laryngology, 2002, v. 259, n. 1, p. 27, doi. 10.1007/PL00007524
- By:
- Publication type:
- Article
Association of Disease Progression With Health-Related Quality of Life Among Adults With Breast, Lung, Pancreatic, and Colorectal Cancer.
- Published in:
- JAMA Network Open, 2020, v. 3, n. 3, p. e200643, doi. 10.1001/jamanetworkopen.2020.0643
- By:
- Publication type:
- Article
Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients—Analysis of the Phase III AIO KRK-0207 Trial.
- Published in:
- Frontiers in Oncology, 2018, p. N.PAG, doi. 10.3389/fonc.2018.00474
- By:
- Publication type:
- Article
Capecitabine and bevacizumab for non-resectable metastatic colorectal cancer patients: final results from phase II AIO KRK 0105 trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases: a randomized, placebo-controlled, multicenter, multinational, double-blinded phase II trial.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial.
- Published in:
- Clinical Chemistry, 2020, v. 66, n. 12, p. 1510, doi. 10.1093/clinchem/hvaa223
- By:
- Publication type:
- Article
New perspectives for cancer chemotherapy by genetic protection of haematopoietic cells.
- Published in:
- Expert Reviews in Molecular Medicine, 1999, v. 1, n. 12, p. 1, doi. 10.1017/S1462399499000769
- By:
- Publication type:
- Article
FOLFIRINOX or gemcitabine/nab‐paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision‐making in real‐world.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 3, p. 458, doi. 10.1002/ijc.34271
- By:
- Publication type:
- Article
Survival after secondary liver resection in metastatic colorectal cancer: Comparing data of three prospective randomized European trials (LICC, CELIM, FIRE‐3).
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 8, p. 1341, doi. 10.1002/ijc.33881
- By:
- Publication type:
- Article
Phase III randomized, double‐blind study of paclitaxel with and without everolimus in patients with advanced gastric or esophagogastric junction carcinoma who have progressed after therapy with a fluoropyrimidine/platinum‐containing regimen (RADPAC)
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 9, p. 2493, doi. 10.1002/ijc.33025
- By:
- Publication type:
- Article
Exposure to lipophilic industrial solvents leads to increased P-glycoprotein expression in peripheral blood cells.
- Published in:
- British Journal of Haematology, 1993, v. 85, n. 1, p. 220, doi. 10.1111/j.1365-2141.1993.tb08678.x
- By:
- Publication type:
- Article
Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Results from the prospective German TPK clinical cohort study: Treatment algorithms and survival of 1,174 patients with locally advanced, inoperable, or metastatic pancreatic ductal adenocarcinoma.
- Published in:
- International Journal of Cancer, 2019, v. 144, n. 5, p. 981, doi. 10.1002/ijc.31751
- By:
- Publication type:
- Article
Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
- Published in:
- International Journal of Cancer, 2017, v. 140, n. 9, p. 2134, doi. 10.1002/ijc.30625
- By:
- Publication type:
- Article
Clinicopathological factors influencing outcome in metastatic colorectal cancer patients treated with fluoropyrimidine and bevacizumab maintenance treatment vs observation: an individual patient data meta-analysis of two phase 3 trials.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
ABC1 Consensus Conference - a German Perspective.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program.
- Published in:
- 2016
- By:
- Publication type:
- journal article